The development and use of the E75 (HER2 369–377) peptide vaccine

od Clifton, Guy T, Peoples, George E, Mittendorf, Elizabeth A
Izdano u Future Oncol (2016)

Clinical Development of the E75 Vaccine in Breast Cancer

od Clifton, Guy T., Gall, Victor, Peoples, George E., Mittendorf, Elizabeth A.
Izdano u Breast Care (Basel) (2016)

Multicenter Trial of Early Hypothermia in Severe Brain Injury

od Clifton, Guy L., Drever, Pamala, Valadka, Alex, Zygun, David, Okonkwo, David
Izdano 2009

ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination

od Adams, Alexandra M., Vreeland, Timothy J., Clifton, Guy T., Peoples, George E.
Izdano u Ann Surg Oncol (2021)

Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury

od Hergenroeder, Georgene W, Moore, Anthony N, McCoy, J Philip, Samsel, Leigh, Ward, Norman H, Clifton, Guy L, Dash, Pramod K
Izdano 2010

Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

od Greene, Julia, Schneble, Erika, Berry, John, Trappey, Alfred, Vreeland, Timothy, Clifton, Guy, McGuire, William, Maxwell, George, Ponniah, Sathibalan, Peoples, George
Izdano u J Immunother Cancer (2014)

Using Technology to Maintain the Education of Residents During the COVID-19 Pandemic

od Chick, Robert Connor, Clifton, Guy Travis, Peace, Kaitlin M., Propper, Brandon W., Hale, Diane F., Alseidi, Adnan A., Vreeland, Timothy J.
Izdano u J Surg Educ (2020)

Feasibility of the Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) in Adults

od Wilde, Elisabeth A., McCauley, Stephen R., Kelly, Tara M., Levin, Harvey S., Pedroza, Claudia, Clifton, Guy L., Valadka, Alex B., Robertson, Claudia S., Moretti, Paolo
Izdano 2010

Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients

od Berry, John S, Schneble, Erika J, Trappey, Alfred F, Vreeland, Timothy J, Clifton, Guy T, Hale, Diane F, Sears, Alan K, Ponniah, Sathibalan, Mittendorf, Elizabeth A, Peoples, George E
Izdano 2013

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

od Jackson, Doreen, Qiao, Na, Greene, Julia M, Hale, Diane, Berry, John, Trappey, Alfred, Vreeland, Timothy, Clifton, Guy, Ibrahim, Nuhad, Toms, Annie, Peoples, George E, Mittendorf, Elizabeth A
Izdano u J Immunother Cancer (2015)

Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation

od Berry, John S, Trappey, Alfred F, Vreeland, Timothy J, Pattyn, Adam R, Clifton, Guy T, Berry, Elizabeth A, Schneble, Erika J, Kirkpatrick, Aaron D, Saenger, Jeffrey S, Peoples, George E
Izdano u J Cancer (2016)

Clinical Trial Results of the HER-2/neu (E75) Vaccine to Prevent Breast Cancer Recurrence in High-Risk Patients: From US Military Cancer Institute Clinical Trials Group Study I-01...

od Mittendorf, Elizabeth A., Clifton, Guy T., Holmes, Jarrod P., Clive, Kevin S., Patil, Ritesh, Benavides, Linda C., Gates, Jeremy D., Sears, Alan K., Stojadinovic, Alexander, Ponniah, Sathibalan, Peoples, George E.
Izdano 2011

Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine

od Greene, Julia, Schneble, Erika, Martin, Jonathan, Flores, Maddie, Trappey, Alfred, Berry, John, Vreeland, Timothy, Hale, Diane, Clifton, Guy, Perez, Sonia A, Papamichail, Michael, Peoples, George, Mittendorf, Elizabeth, Ponniah, Sathibalan
Izdano u J Immunother Cancer (2014)

Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients

od Schneble, Erika J, Berry, John S, Trappey, Alfred F, Vreeland, Timothy J, Hale, Diane F, Sears, Alan K, Clifton, Guy T, Ponniah, Sathibalan, Shumway, Nathan M, Mittendorf, Elizabeth A, Peoples, George E
Izdano 2013

The Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI): I. Construct Validity

od Wilde, Elisabeth A., McCauley, Stephen R., Kelly, Tara M., Weyand, Annie M., Pedroza, Claudia, Levin, Harvey S., Clifton, Guy L., Valadka, Alex B., Schnelle, Kathleen P., Shah, Monika V., Moretti, Paolo
Izdano 2010

Phase Ib Trial of Folate Binding Protein (FBP)-Derived Peptide Vaccines, E39 and an Attenuated Version, E39′: An Analysis of Safety and immune Response

od Vreeland, Timothy J., Litton, Jennifer K., Qiao, Na, Philips, Anne V., Alatrash, Gheath, Hale, Diane F., Jackson, Doreen O., Peace, Kaitlin M., Greene, Julia M., Berry, John S, Clifton, Guy T., Peoples, George E
Izdano u Clin Immunol (2018)

Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and Outcomes

od Vreeland, Timothy J, Berry IV, John S, Schneble, Erika, Jackson, Doreen O, Herbert, Garth S, Hale, Diane F, Martin, Jonathon M, Flores, Madeline, Pattyn, Adam R, Hata, Kai, Clifton, Guy T, Kirkpatrick, Aaron D, Peoples, George E.
Izdano u J Cancer (2017)

Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement

od Kemp Bohan, Phillip M., Chick, Robert C., Hickerson, Annelies T., Messersmith, Lynn M., Williams, Grant M., Cindass, Jessica L., Lombardo, Jamie, Collins, Ryan, Brady, Robert O., Hale, Diane F., Peoples, George E., Vreeland, Timothy J., Clifton, Guy T.
Izdano u Cancer Immunol Immunother (2020)

Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma

od McCarthy, Patrick M, Rendo, Matthew J, Uy, Matthew D, Adams, Alexandra M, O’Shea, Anne E, Nelson, Daniel William, Fenderson, Joshua L, Cebe, Katherine M, Krell, Robert W, Clifton, Guy T, Peoples, George E, Vreeland, Timothy J
Izdano u Onco Targets Ther (2021)

Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells

od Gall, Victor A., Philips, Anne V., Qiao, Na, Clise-Dwyer, Karen, Perakis, Alexander A., Zhang, Mao, Clifton, Guy T., Sukhumalchandra, Pariya, Ma, Qing, Reddy, Sangeetha M., Yu, Dihua, Molldrem, Jeffrey J., Peoples, George E., Alatrash, Gheath, Mittendorf, Elizabeth A.
Izdano u Cancer Res (2017)